drugset / Trial / NCT00514306
Study of Intermittent OSI-906 Dosing
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Multicenter, open-label, phase 1, cohort dose escalation study to determine the maximum tolerated dose (MTD) of 3 intermittent OSI-906 dosing schedules.
Timeline
- Start
- 2007-07-05
- Primary completion
- 2010-09-20
- Completion
- 2010-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | linsitinib | Small molecule | — | Oral |